Independent Study Validates Bio Rad’s Droplet Digital™ PCR Technology for Analyzing Archival Cancer Samples
Published: Friday, December 14, 2012 Last Updated: Friday, December 14, 2012
Stanford University and Bio-Rad demonstrated that the QX100™ Droplet Digital PCR (ddPCR™) system enables accurate and precise measurements of cancer genome amplifications in archival cancer tissue samples.
Full access to this article is for registered users only. Registration is free-of-charge and allows access to all content on our web communities.
Already registered? Then please log in at the top of the page.